Chronic excess hyperlipidemia. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Liver Adipose Tissue Aorta Kidney Endothelium, Vascular Carotid Arteries Macrophages Chromosomes, Human, Pair 1 Cells, Cultured Foam Cells

Organisms16

Gynostemma Mice, Inbred C57BL Mice, Knockout Gadiformes Rats, Sprague-Dawley Rats, Zucker Mice, Transgenic Angelica sinensis Tamarindus Rats, Wistar Spirulina Rabbits Mice, Obese Rats, Inbred Strains Rats, Mutant Strains Plants, Medicinal

Diseases53

Hyperlipidemia, Familial Combined Hyperlipidemias Hypertriglyceridemia Hyperlipoproteinemia Type IV Hypercholesterolemia Xanthomatosis Arteriosclerosis Obesity Hyperlipoproteinemia Type II Atherosclerosis Hyperlipoproteinemia Type III Hypertension Diabetes Mellitus Body Weight Insulin Resistance Fatty Liver Dyslipidemias Diabetes Mellitus, Type 2 Hyperlipoproteinemias Cardiovascular Diseases Disease Models, Animal Nephrotic Syndrome Hyperlipoproteinemia Type V Hyperglycemia Hyperlipoproteinemia Type I Diabetes Complications Coronary Disease Diabetes Mellitus, Experimental Metabolic Syndrome X Coronary Artery Disease Empty Sella Syndrome Glomerulosclerosis, Focal Segmental Proteinuria Intestinal Polyposis Stroke Anemia, Refractory, with Excess of Blasts Hyperinsulinism Nephrosis Metabolic Diseases Lipodystrophy Kidney Diseases Hyperhomocysteinemia Rhabdomyolysis Erectile Dysfunction Weight Gain Intracranial Arteriosclerosis Genetic Predisposition to Disease Carotid Artery Diseases Myocardial Infarction Thrombosis Diabetic Angiopathies Obesity, Morbid Kidney Failure, Chronic

Chemicals and Drugs100

Triglycerides Hypolipidemic Agents Lipids Cholesterol Cholesterol, LDL Lipoproteins Apolipoproteins E Apolipoproteins B Cholesterol, HDL Apolipoproteins C Apolipoprotein E2 Apolipoprotein C-III Lipoprotein Lipase Fenofibrate Lipoproteins, VLDL Anticholesteremic Agents Hydroxymethylglutaryl-CoA Reductase Inhibitors Lipoproteins, LDL Apolipoproteins Cholesterol, VLDL Receptors, LDL Dietary Fats Poloxamer Heptanoic Acids Blood Glucose Apolipoprotein A-I Cholesterol, Dietary Bezafibrate Epichlorohydrin Apolipoproteins A Simvastatin Insulin Pyrroles Fatty Acids, Nonesterified Apolipoprotein E3 Gemfibrozil Apolipoprotein B-48 Lipoproteins, IDL Lipase Chylomicrons Pravastatin Apolipoprotein A-II Apolipoprotein B-100 Upstream Stimulatory Factors Plant Extracts Fatty Acids Apolipoprotein C-I Lipoproteins, HDL Lovastatin Sterol Regulatory Element Binding Proteins Cholesterol Ester Transfer Proteins Sterol O-Acyltransferase Azetidines Hypoglycemic Agents Biological Markers Stearoyl-CoA Desaturase RNA, Messenger Sterol Regulatory Element Binding Protein 1 Niacin Dietary Sucrose Clofibric Acid Cyclooctanes Resins, Synthetic Carrier Proteins PPAR alpha Leptin Bile Acids and Salts Group IB Phospholipases A2 Cholesterol Esters Lipoprotein(a)Fatty Acids, Monounsaturated Clofibrate Hemoglobin A, Glycosylated Phytosterols Glucose Adiponectin Diacylglycerol O-Acyltransferase Receptors, Lipoprotein Soybean Proteins Cholestyramine Resin Hydroxymethylglutaryl CoA Reductases Antioxidants HIV Protease Inhibitors Fat Emulsions, Intravenous Anti-Obesity Agents Antigens, CD36 Drugs, Chinese Herbal Immunosuppressive Agents Phospholipids Phosphatidylcholine-Sterol O-Acyltransferase Resistin Blood Proteins Streptozocin Phosphodiesterase 5 Inhibitors Fluorobenzenes Antihypertensive Agents Apolipoprotein C-II Fatty Acids, Omega-3 Cyclosporine Sterols

Analytical, Diagnostic and Therapeutic Techniques and Equipment38

Risk Factors Obesity Diet, Atherogenic Body Weight Disease Models, Animal Phytotherapy Treatment Outcome Retrospective Studies Diabetes Mellitus, Experimental Pedigree Prevalence Body Mass Index Risk Assessment Diet, Fat-Restricted Cohort Studies Regression Analysis Follow-Up Studies Organ Size Diet Therapy Prospective Studies Case-Control Studies Blood Pressure Incidence Glucose Tolerance Test Apitherapy Logistic Models Cross-Sectional Studies Double-Blind Method Drug Therapy, Combination Reference Values Kidney Transplantation Chi-Square Distribution Risk Odds Ratio Multivariate Analysis Severity of Illness Index Obesity, Morbid Registries

Psychiatry and Psychology4

Fasting Smoking Erectile Dysfunction Life Style

Phenomena and Processes42

Lipid Metabolism Obesity Diet, Atherogenic Body Weight Insulin Resistance Postprandial Period Time Factors Diet Diet, High-Fat Phenotype Lipolysis Body Mass Index Diet, Fat-Restricted Fasting Organ Size Particle Size Oxidation-Reduction Alleles Gene Expression Regulation Blood Pressure Genetic Linkage Oxidative Stress Kinetics Polymorphism, Genetic Dose-Response Relationship, Drug Base Sequence Eating Genotype Lipogenesis Heterozygote Gene Expression Weight Gain Chi-Square Distribution Risk Homozygote Genetic Predisposition to Disease Intestinal Absorption Odds Ratio Chromosomes, Human, Pair 1 Polymorphism, Single Nucleotide Obesity, Morbid Haplotypes

Technology, Industry, Agriculture6

Dietary Fats Poloxamer Dietary Sucrose Resins, Synthetic Soybean Proteins Cholestyramine Resin

Information Science5

Prevalence Incidence Base Sequence Molecular Sequence Data Registries

Health Care25

Risk Factors Age Factors Treatment Outcome Retrospective Studies Sex Factors Prevalence Body Mass Index Risk Assessment Cohort Studies Regression Analysis Comorbidity Follow-Up Studies Family Health Prospective Studies Case-Control Studies Incidence Logistic Models Cross-Sectional Studies Double-Blind Method Chi-Square Distribution Risk Odds Ratio Multivariate Analysis Severity of Illness Index Registries

Geographicals4

Japan United States Finland Taiwan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Technology, Industry, Agriculture Information Science Health Care Geographicals

Hyperlipidemia, Familial Combined Hyperlipidemias Triglycerides Hypolipidemic Agents Lipids Cholesterol Hypertriglyceridemia Cholesterol, LDL Hyperlipoproteinemia Type IV Lipoproteins Lipid Metabolism Apolipoproteins E Hypercholesterolemia Apolipoproteins B Cholesterol, HDL Apolipoproteins C Apolipoprotein E2 Apolipoprotein C-III Lipoprotein Lipase Fenofibrate Lipoproteins, VLDL Xanthomatosis Risk Factors Liver Anticholesteremic Agents Arteriosclerosis Hydroxymethylglutaryl-CoA Reductase Inhibitors Lipoproteins, LDL Obesity Apolipoproteins Cholesterol, VLDL Gynostemma Receptors, LDL Dietary Fats Hyperlipoproteinemia Type II Atherosclerosis Hyperlipoproteinemia Type III Poloxamer Hypertension Heptanoic Acids Diabetes Mellitus Blood Glucose Diet, Atherogenic Mice, Inbred C57BL Apolipoprotein A-I Cholesterol, Dietary Body Weight Insulin Resistance Postprandial Period Fatty Liver Dyslipidemias Bezafibrate Epichlorohydrin Apolipoproteins A Diabetes Mellitus, Type 2 Simvastatin Insulin Hyperlipoproteinemias Cardiovascular Diseases Disease Models, Animal Pyrroles Nephrotic Syndrome Mice, Knockout Hyperlipoproteinemia Type V Time Factors Fatty Acids, Nonesterified Diet Apolipoprotein E3 Gemfibrozil Hyperglycemia Apolipoprotein B-48 Gadiformes Lipoproteins, IDL Lipase Diet, High-Fat Chylomicrons Pravastatin Phenotype Phytotherapy Apolipoprotein A-II Apolipoprotein B-100 Upstream Stimulatory Factors Hyperlipoproteinemia Type I Adipose Tissue Diabetes Complications Age Factors Coronary Disease Plant Extracts Treatment Outcome Retrospective Studies Fatty Acids Apolipoprotein C-I Lipoproteins, HDL Lovastatin Lipolysis Diabetes Mellitus, Experimental Sterol Regulatory Element Binding Proteins Pedigree Metabolic Syndrome X Cholesterol Ester Transfer Proteins

No FAQ available that match "chronic excess hyperlipidemia"